Hypertonic saline nasal irrigation in the management of allergic rhinitis and chronic sinusitis by Grech, David
AdVERTORIAL
Hypertonic saline nasal irrigation 
in the management of allergic rhinitis 
and chronic sinusitis
dAVId GRECH
References 
1. Parikh A, Scadding GK. Seasonal allergic 
rhinitis. Br Med J 1997; 314: 1392–5.
2. Garavello W et al. Hypersaline nasal irrigation 
in children with symptomatic seasonal allergic 
rhinitis: A randomized study. Pediatr Allergy 
Immunol 2003; 14: 140-143
3. Rabago D et al. Qualitative aspects of nasal 
irrigation use by patients with chronic sinus 
disease in a multimethod study. Ann Fam Med 
2006;4: 295-301
4. Shoseyov D et al. Treatment with hypertonic 
saline versus normal saline nasal wash of 
pediatric chronic sinusitis. J Allergy Clin 
Immunol 1998; 101: 602-5
5. Tomooka LT, Murphy C, Davidson TM. Clinical 
study and literature review of nasal irrigation. 
Laryngoscope 2000; 110: 1189–93.
Source: 
Garavello W et al 
Hypersaline nasal 
irrigation in children 
with symptomatic 
seasonal allergic 
rhinitis: A 
randomized study. 
Pediatr Allergy 
Immunol 2003; 14: 
140-143
Tamooka et al. have also reported 
that nasal wash is efficient in the 
treatment of seasonal allergic rhinitis 
in adults.5 These authors documented 
a significant improvement in the 
symptoms score after nasal irrigation 
with hypertonic saline.
It has been shown that the 
hyperosmolar airway fluids resulting 
from hypertonic saline nasal irrigation 
(HSNI) increase ciliary beat frequency, 
possibly by regulating the use or 
availability of adenosine triphosphate 
by the ciliary axoneme. This enhances 
mucociliary clearance, facilitating the 
evacuation of potentially allergen- and 
irritant-containing mucus. The topical 
antibacterial effect of hypertonic 
saline solution is also well established 
in wound dressing and washing of 
open wounds.4
In summary, daily HSNI is a 
safe, effective and tolerable therapy 
associated with high patient 
satisfaction, improved quality of 
life, decreased antibiotic use, and 
improved sinus symptoms in both 
paediatric and adult patients with 
a history of frequent rhinosinusitis 
and chronic sinus complaints. 
Study participants also expressed 
satisfaction in their perception that 
at-home use of HSNI reduced the 
number of trips to their physician 
and the number of antibiotic 
prescriptions.3    
Allergic rhinitis is a disease characterized by the classic 
symptoms of rhinorrhea, obstruction 
of the nasal passage, sneezing 
and itching, all occurring in a 
temporal relationship to allergen 
exposure.1 Conventional treatment 
options include antihistamines, 
decongestants, anticholinergics and 
corticosteroids.1,2 
If untreated or in the long term, 
chronic inflammation of the maxillary 
sinuses may result in  increased 
secretions from the sinuses and 
postnasal drip caused by the allergic 
response. The mucosa becomes 
swollen and hypertrophic. The 
impaired drainage of the secretion 
from the sinuses (especially from 
the maxillary sinuses) increases the 
likelihood of recurrent infections. The 
conventional medical approach to 
chronic sinusitis includes treatment 
with local and systemic anti-
inflammatory  drugs with or without 
antibiotics.3
Many patients with sinusitis also 
experience chronic cough, fatigue 
and lassitude characteristic of the 
disease. The prevalence of chronic 
sinusits among patients with respiratory 
complaints is estimated to be as high 
as 38% in children older than 10 years 
of age.3
Recent studies have documented 
interesting results using nasal irrigation 
as an adjunctive treatment modality 
in many sinonasal diseases. In this 
regard, it has also been reported that 
an increased efficacy could be effected 
using hypertonic (2 – 3.5% w/v) saline 
instead of normal saline.4
Significant clinical benefits were 
observed in children with seasonal 
allergic rhinitis who received a regimen 
of three-times daily nasal irrigation 
with hypertonic saline during the pollen 
season (Figure 1). Indeed, the mean 
daily rhinitis score was reduced during 
the study treatment period (6 weeks). 
Reduced need for oral antihistamines 
was also observed.1
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